Eyegene
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Dmc Bldg #414 1580 Samgam-dong Mapo-gu, ...Phone Number
+82 23221687Website
www.eyegene.co.krRevenue
<$5 MillionStock Symbol
185490Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Eyegene
EYEGENE is a leader in gene and cell therapy, focusing on innovative treatments and prevention of diseases through scientific discovery. The company is dedicated to creating a healthier future by developing mRNA vaccines, AAV gene therapies, and other advanced biopharmaceuticals. Their mission emphasizes trust, collaboration, and continuous innovation, aiming to enhance the quality of life globally. EYEGENE seeks to attract talented individuals who are committed to ethical practices and scientific excellence in the field of biomedicine.Explore more
Popular SearchesEyegene IncSIC Code 87,873NAICS Code 54,541Ticker KRX: 185490Show moreEyegene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eyegene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Eyegene had a recent Job posting/layoffs
Earning: See what the market has to say on Eyegene recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Eyegene launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Eyegene is spiking on competitors!
Eyegene, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Eyegene has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Eyegene has new funding data
Congratulate Masked Content for being promoted to Masked Content at Eyegene
Recommended Actions
Reach out to Masked Content who joined Eyegene as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Eyegene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Eyegene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Eyegene.
Eyegene Tech Stack
A closer look at the technologies used by Eyegene
See more technologies
Eyegene News & Media
GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea
NANJING, China, Sept. 27, 2021 /PRNewswire/ -- EyeGene's mRNA vaccine against COVID-19, namely "EG-COVID", has recently been approved for clinical trials by South Korea's Ministry of Food and Drug Safety (MFDS). GenScript ProBio hereby extended its warm congratulations to the partner. EG-COVID will undergo a Phase I/IIa clinical trial to test the safety, tolerability and immunogenicity of the vaccine. GenScript ProBio, as a partner of EyeGene, will provide the project with plasmids for mRNA vacc
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Eyegene
Sign Up For FreeTo access detailed company insights
EYEGENE is a leader in gene and cell therapy, focusing on innovative treatments and prevention of diseases through scientific discovery. The company is dedicated to creating a healthier future by developing mRNA vaccines, AAV gene therapies, and other advanced biopharmaceuticals. Their mission emphasizes trust, collaboration, and continuous innovat... Read More
